Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A.

J Clin Invest. 2008 Feb;118(2):534-44. doi: 10.1172/JCI33194.

2.

Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.

Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA.

PLoS Med. 2008 Mar 4;5(3):e54. doi: 10.1371/journal.pmed.0050054.

3.

Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.

Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH.

World J Gastroenterol. 2013 May 7;19(17):2638-49. doi: 10.3748/wjg.v19.i17.2638.

4.

Interleukin-19 protects mice from innate-mediated colonic inflammation.

Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, Nakajima H, Karow M, Takeuchi T.

Inflamm Bowel Dis. 2010 Jun;16(6):1017-28. doi: 10.1002/ibd.21151.

PMID:
19834971
5.

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice.

Sedhom MA, Pichery M, Murdoch JR, Foligné B, Ortega N, Normand S, Mertz K, Sanmugalingam D, Brault L, Grandjean T, Lefrancais E, Fallon PG, Quesniaux V, Peyrin-Biroulet L, Cathomas G, Junt T, Chamaillard M, Girard JP, Ryffel B.

Gut. 2013 Dec;62(12):1714-23. doi: 10.1136/gutjnl-2011-301785. Epub 2012 Nov 21.

6.

Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.

Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, Touil-Boukoffa C.

Immunopharmacol Immunotoxicol. 2013 Jun;35(3):403-9. doi: 10.3109/08923973.2013.790413. Epub 2013 May 2.

PMID:
23638770
7.

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C.

J Exp Med. 2009 Jul 6;206(7):1465-72. doi: 10.1084/jem.20082683. Epub 2009 Jun 29.

8.

Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells.

Rahman A, Fahlgren A, Sundstedt C, Hammarström S, Danielsson A, Hammarström ML.

Clin Exp Immunol. 2011 Jan;163(1):123-30. doi: 10.1111/j.1365-2249.2010.04282.x. Epub 2010 Oct 29.

10.

Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.

Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N, Kido M, Inoue S, Mikami S, Asada M, Kiriya K, Kitamura H, Ohashi S, Fukui T, Kawasaki K, Matsuura M, Ishii Y, Okazaki K, Yodoi J, Chiba T.

Gastroenterology. 2006 Oct;131(4):1110-21. Epub 2006 Aug 9.

PMID:
17030181
11.

A role for interleukin-33 in T(H)2-polarized intestinal inflammation?

Seidelin JB, Rogler G, Nielsen OH.

Mucosal Immunol. 2011 Sep;4(5):496-502. doi: 10.1038/mi.2011.22. Epub 2011 May 25. Review.

PMID:
21613987
12.

Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.

Yang X, Zhang F, Wang Y, Cai M, Wang Q, Guo Q, Li Z, Hu R.

Inflamm Bowel Dis. 2013 Aug;19(9):1990-2000. doi: 10.1097/MIB.0b013e318293c5e0.

PMID:
23823704
13.

The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway.

Ratsimandresy RA, Indramohan M, Dorfleutner A, Stehlik C.

Cell Mol Immunol. 2017 Jan;14(1):127-142. doi: 10.1038/cmi.2016.35. Epub 2016 Aug 15.

14.

Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells.

Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Fränk M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R.

Am J Pathol. 2013 Mar;182(3):1005-20. doi: 10.1016/j.ajpath.2012.11.026.

PMID:
23438478
15.

γδ T-cell-deficient mice show alterations in mucin expression, glycosylation, and goblet cells but maintain an intact mucus layer.

Kober OI, Ahl D, Pin C, Holm L, Carding SR, Juge N.

Am J Physiol Gastrointest Liver Physiol. 2014 Apr 1;306(7):G582-93. doi: 10.1152/ajpgi.00218.2013. Epub 2014 Feb 6.

16.

Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization.

Lin Y, Yang X, Yue W, Xu X, Li B, Zou L, He R.

Cell Mol Immunol. 2014 Jul;11(4):355-66. doi: 10.1038/cmi.2014.15. Epub 2014 Apr 14.

17.

Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.

Tang R, Yang G, Zhang S, Wu C, Chen M.

Inflamm Bowel Dis. 2014 Nov;20(11):1950-61. doi: 10.1097/MIB.0000000000000192.

PMID:
25208103
18.

Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.

De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, Adda S, Hoffman J, Kahoud N, Garlapati R, Shyamsundar R, Mai K, Zhang J, Muchamuel T, Dajee M, Schryver B, McEvoy LM, Ehrhardt RO.

Gut. 2007 Apr;56(4):524-33. Epub 2006 Sep 1.

19.

IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient.

Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P.

Sci Transl Med. 2010 Dec 1;2(60):60ra88. doi: 10.1126/scitranslmed.3001500.

20.

Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms.

Pandurangan AK, Mohebali N, Esa NM, Looi CY, Ismail S, Saadatdoust Z.

Int Immunopharmacol. 2015 Oct;28(2):1034-43. doi: 10.1016/j.intimp.2015.08.019. Epub 2015 Aug 28.

PMID:
26319951

Supplemental Content

Support Center